Thesis TrackerLazard Asset Management has spent the past year buying former quality growth stocks after steep falls. It added Cochlear in April, has already sold Woolworths, and points to EBOS and Light & Wonder as examples of what it looks for.
1851 Capital re-initiated a position in Generation Development Group (ASX:GDG) below $3 after crowded ownership eased. It had been cautious after seeing many fund managers at an investor day, believing limited new buyers remained, but bought back as valuation and ownership improved.
Pengana Capital Group slightly trimmed Generation Development Group (ASX:GDG) about five months earlier due to higher ASIC compliance costs after First Guardian and Shield. The stock has fallen after over-promising on Evidentia inflows and higher-than-flagged integration investment, making it heavily shorted. Pengana remains highly excited, expecting 25%-plus earnings growth on a market multiple, and keeps it as a high-conviction top-five holding.
General information only. Thesis Tracker is a database of what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
12,813 comments from 172 managers on 780 companies, snapshot 13 Nov 2026.
Lazard Asset Management has spent the past year buying former quality growth stocks after steep falls. It added Cochlear in April, has already sold Woolworths, and points to EBOS and Light & Wonder as examples of what it looks for.
1851 Capital re-initiated a position in Generation Development Group (ASX:GDG) below $3 after crowded ownership eased. It had been cautious after seeing many fund managers at an investor day, believing limited new buyers remained, but bought back as valuation and ownership improved.
Pengana Capital Group slightly trimmed Generation Development Group (ASX:GDG) about five months earlier due to higher ASIC compliance costs after First Guardian and Shield. The stock has fallen after over-promising on Evidentia inflows and higher-than-flagged integration investment, making it heavily shorted. Pengana remains highly excited, expecting 25%-plus earnings growth on a market multiple, and keeps it as a high-conviction top-five holding.
General information only. Thesis Tracker is a database of what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
12,813 comments from 172 managers on 780 companies, snapshot 13 Nov 2026.
